Jeunesse Global makes beauty possible for millions with Instantly Ageless

When Randy Ray and Wendy Lewis finally decided to permanently move to their Florida home and retire, they were far from the typical snowbird retirees. Ray and Lewis had spent their entire careers in the direct-marketing business, building and growing some of the top companies in the industry and making themselves a fortune by the time they were in their early 30s. Almost four decades later, the dynamic couple believed that they had finally reached the point in their lives when they could sit back, relax and enjoy the fruits of their labor.

But in retiring, Ray and Lewis failed to account for one thing: They were both born entrepreneurs. Within a couple of weeks, the reality of not having goals to passionately pursue and the having days filled with no meaningful activities began to sink in. It didn’t take long for the inveterate go-getters to begin selling a few things out of their garage. Before long, they had come up with a new business plan. The couple would sell health and beauty products and, at the same time, give aspiring business owners across the globe the chance to own their own business and experience real American-style economic opportunity. This marked the beginning of Jeunesse Global.

Just over eight years later, Jeunesse Global now stands as the fastest-growing company in the history of the global health and beauty industry. With tens of thousands of distributors and millions of customers across the globe, Jeunesse has taken the world of health and beauty by storm. While the company ranks among the best direct-marketing firms in the world to get involved with as a distributor, the real secret behind the company’s success has been its innovative products.

One example is the firm’s Instantly Ageless micro-crème. As a deep facial cleanser, Instantly Ageless is without peers. But the product really shines in the area of aging prevention. Made with Jeunesse Global’s patented APT-200 anti-aging molecule, Instantly Ageless has been clinically shown to prevent wrinkles, restore youthful elasticity and give skin a vibrant hue that can erase years of apparent age off of a user’s face.

https://www.instagram.com/jeunessehq/

https://www.crunchbase.com/organization/jeunesse-global-2

Dr. Sameer Jejurikar Cares for and About His Patients

Dr. Sameer Jejurikar is a board-certified plastic surgeon and voted one of the most compassionate doctors in the United States according to the patients themselves. In 2012 the Dallas, Texas-based Jejurikar was presented with the Compassionate Doctor Certification. This award was based on 100 million patients who reviewed their physicians online through sites like Patients’ Choice and Vitals. This honor was only bestowed upon about 3% of the active physicians in the United States. Dr. Sameer Jejurikar, known as Dr. Sam to his patients, received near perfect scores on patient ratings.

 

A member of the Alpha Omega Alpha Honor Society upon receipt of his MD through the University of Michigan Medical School, he also earned his bachelors at the University of Michigan as well as completing his residency through their medical center. Jejurikar is a member of both the American Society for Aesthetic Plastic Surgery and the American Society of Plastic Surgeons. In 2006, he completed an aesthetic surgery fellowship at the Manhattan Eye, Ear, and Throat Hospital.

 

The world-renowned Dallas Plastic Surgery Institute is where Dr. Sameer has worked out of for almost 9 years, since 2009. Prior to this, he was a senior staff surgeon for Scott and White. He specializes in both reconstructive and aesthetic surgery which makes him a top choice for complicated cases of surgery. His compassion for his patients makes the process easier as he cares for them mentally as well as physically. This stress-reducing method can help make the healing process smoother and make the actual surgery less traumatic. He specializes in liposuction, tummy tucks, breast augmentations and more. He strives to help patients achieve their vision in the safest way he can.

 

Amicus Therapeutics, Restoring Hope to People with Rare Diseases

New diseases are emerging every day. The drugs which were being used a decade ago are not as effective as they used to be back then. This scenario has given doctors a hard time as they try to come up with new ways to treat new diseases. Amicus Therapeutics is a biotechnology company that focuses on finding ways to fight rare and orphan illnesses through the use of therapies. The global company uses unique technology and medicine as well to help people suffering from devastating diseases such as Lysosomal Storage Disorders, skin disorders, and Pompe disease.

 

Amicus Therapeutics was founded in 2002 and has around five hundred employees. It has its headquarters in Cranbury, New Jersey. The company cares for the many patients suffering from rare diseases which have troubled doctors from other medical institutions and ensures that they get the best care possible. The specialists in the company come up with clinical programs and carry out inventive science to create a platform where these people with the rare disorders can seek medical attention and be treated.

 

The goal of Amicus Therapeutics is to make a difference that is meaningful in the lives of all those patients with these critical conditions (https://www.dialdish.com/amicus-therapeutics-fabry-disease/). Many patients who have received help from the company and recovered fully from the special conditions claim that they had suffered for a long time before hearing about Amicus Therapeutics. Many reports that they were almost giving up after searching for solutions from many hospitals and clinics without success. That is how important the company is; for many people, it is usually the last hope.

 

Before 2008, Amicus Therapeutics had only one site, which was located in New Jersey (AliveNewspaper). This was before the company opened another one in San Diego. The company has received financial support from many sources due to its good work including grants from the Michael J. Fox Foundation and Alzheimer’s Drug Discovery Foundation.

 

Today, Amicus Therapeutics continues to look for better ways to help patients under the leadership of John F. Crowley who is the CEO and chairman of the company. Patients with these rare disorders will continue to get the help they need from the medical specialists for many years to come.